The BalancedInvestor Club

Biotechnology Industry Analysis

717 companies analyzed • Returns from -660.8% to +460.5%

Company List (719 Results)

View:
Sort:

Industry Performance

(717/717 companies)
2025-09-02 → 2026-08-31
Weighted Avg
+24.9%
Best
+460.5%
Worst
-660.8%
Returns Distribution
Top 5
1. CUBT+460.5%2. RVMDW+409.2%3. CUE+347.1%4. RLYB+340.5%5. PMN+319.3%
Bottom 5
1. LYRA-660.8%2. CERO-655.1%3. CARM-582.4%4. HUMAW-545.3%5. ADTX-502.4%

CUBT

+460.5%

Curative Biotechnology Inc

RVMDW

+409.2%

Revolution Medicines, Inc. Warrant

CUE

+347.1%

Cue Biopharma

RLYB

+340.5%

Rallybio Corp

PMN

+319.3%

ProMIS Neurosciences Inc.

GNPX

+315.5%

Genprex Inc

STRO

+305.8%

Sutro Biopharma

ATHA

+305.6%

Athira Pharma Inc

LONA

+301.9%

Athira Pharma Inc

QNCX

+301.3%

Quince Therapeutics, Inc.

IMUX

+298.4%

Immunic Inc

ASBP

+274.8%

Aspire BioPharma, Inc.

INTS

+272.8%

Intensity Therapeutics, Inc. Common stock

ADIL

+272.6%

Adial Pharmaceuticals Inc

AKTX

+270.1%

Akari Therapeutics PLC

PLRZ

+260.7%

Polyrizon Ltd. Ordinary Shares

XLO

+254.2%

Xilio Development Inc

LEXX

+253.4%

Lexaria Bioscience Corp

DRTSW

+250.7%

Alpha Tau Medical Ltd. Warrant

ACET

+247.2%

Adicet Bio Inc

1–20 of 719
Page 1 of 36
Methodology

The Weighted Average return (+24.9%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

669 companies with market cap data included: CUBT, CUE, RLYB, PMN, GNPX, STRO, ATHA, LONA, QNCX, IMUX and 659 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer